Nilotinib-induced Keratosis Pilaris Associated with Alopecia Areata and Eyebrow Thinning

Tyrosine kinase enzymes are an attractive target for anticancer therapies. Tyrosine kinase inhibitors (TKI) are well tolerated; somehow severe systemic side effects are rarely seen during treatment. Toxicities of skin and appendages may lead to poor compliance, psychosocial inconvenience, and drug i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tawil, Maya Halabi, El Khoury, Rana, Tomb, Roland, Ghosn, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551315/
https://www.ncbi.nlm.nih.gov/pubmed/28839396
http://dx.doi.org/10.4103/ijt.ijt_1_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551315/
https://www.ncbi.nlm.nih.gov/pubmed/28839396
http://dx.doi.org/10.4103/ijt.ijt_1_17

Ejemplares similares